Kolexia
Reyal Fabien
Gynécologie
Clcc Institut Curie
Paris, France
841 Activités
1.2 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Métastase tumorale Récidive tumorale locale Tumeurs du sein triple-négatives Métastase lymphatique Carcinome canalaire du sein Micrométastase tumorale Invasion tumorale

Industries

AVATAR MEDICAL
8 collaboration(s)
Dernière en 2021
B3TSI
2 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2023
AstraZeneca
1 collaboration(s)
Dernière en 2021

Dernières activités

Sentinel Lymph Node biopsy in uterine cancers (Fr /En)
Invivox   12 juin 2024
Neo-CheckRay: Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: a Phase ll Randomised Trial
Essai Clinique (Jules Bordet Institute)   13 mars 2024
Initial experience of guided magnetic marker in non-palpable breast excision: first 80 cases in a French centre
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   01 février 2024
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib.
British journal of cancer   27 janvier 2024
GrannyFit: Digital Phenotyping (Physical Activity, Sleep) in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment
Essai Clinique (Institut Curie)   26 janvier 2024
NeoFit: Digital Phenotyping (Physical Activity, Heart Rate, Sleep) in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Essai Clinique (Institut Curie)   26 janvier 2024
Pr Fabien Reyal for Meta
Youtube @ Avatar Medical   01 décembre 2023
Effects of gender and socio-environmental factors on health-care access in oncology: a comprehensive, nationwide study in France.
EClinicalMedicine   01 novembre 2023
Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns.
JAMA network open   02 octobre 2023
356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023